¹ÙÀÌ·¯½º Ŭ¸®¾î·±½º ½ÃÀå : Á¡À¯À², ±Ô¸ð, µ¿Çâ, »ê¾÷ ºÐ¼® º¸°í¼­ : ¹æ¹ýº°, ¿ëµµº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2024-2032³â)
Viral Clearance Market Share, Size, Trends, Industry Analysis Report, By Method (Viral Removal Method, Viral Inactivation Method, and Viral Detection Method); By Application; By End User; By Region; Segment Forecast, 2024 - 2032
»óǰÄÚµå : 1463090
¸®¼­Ä¡»ç : Polaris Market Research
¹ßÇàÀÏ : 2024³â 03¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 120 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,250 £Ü 5,810,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,250 £Ü 7,177,000
PDF (Multi User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ 20¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,250 £Ü 8,544,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

Polaris Market ResearchÀÇ ÃֽŠÁ¶»ç¿¡ µû¸£¸é ¼¼°èÀÇ ¹ÙÀÌ·¯½º Ŭ¸®¾î·±½º ½ÃÀå ±Ô¸ð´Â 2032³â±îÁö 14¾ï 6,476¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ ¼³¹®Á¶»ç º¸°í¼­´Â ÇöÀç ½ÃÀå ¿ªÇÐÀ» ÀÚ¼¼È÷ ÆÄ¾ÇÇϰí ÇâÈÄ ½ÃÀå ¼ºÀå¿¡ ´ëÇÑ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

¹ÙÀÌ¿À½Ã¹Ð·¯¿Í Á¦³×¸¯ ÀǾàǰ¿¡ ´ëÇÑ ¼¼°è ¼ö¿ä Áõ°¡¿Í ¸¸¼º Áúȯ¿¡ ´ëÇÑ °íµµ·Î Àú·ÅÇÑ Ä¡·á¿¡ ´ëÇÑ ¿ä±¸ Áõ°¡´Â ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÇöÀúÇÑ ¿äÀÎÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ °³¹ß Ãʱ⠴ܰ迡¼­ ¹ÙÀÌ·¯½º Ŭ¸®¾î·±½º ¹× ºÒȰ¼ºÈ­ °ËÃâÀÇ º¸±ÞÀÌ ±Þ¼ÓÈ÷ ÁøÇàµÇ°í ÀÖÀ¸¸ç, ´ë±â¾÷ Á¦¾à ±â¾÷°ú »ý¸í °øÇÐ ±â¾÷ »çÀÌ¿¡¼­ ¹ÙÀÌ·¯½º Ŭ¸®¾î·±½º ¾Æ¿ô¼Ò½Ì¿¡ ´ëÇÑ ¼±È£µµ°¡ ³ô¾ÆÁö°í ÀÖ´Â °Íµµ ¼¼°è ½ÃÀå ¼ºÀåÀ» ´õ¿í ¹Ð¾î¿Ã¸± °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¿¹¸¦ µé¾î, 2023³â 6¿ù, TexcellÀº ºÏ¹Ì¿¡ ÃֽнÃÇè ½Ã¼³À» °³¼³ÇÑ´Ù°í ¹ßÇ¥Çß½À´Ï´Ù. ÀÌ´Â ¹ÙÀÌ¿À Ä¡·áÁ¦ ¹× ÀÇ·á±â±âÀÇ ¹ÙÀÌ·¯½º ¾ÈÀü¼º Çâ»óÀ» À§ÇÑ È¸»çÀÇ ³ë·ÂÀ» º¸¿©ÁÝ´Ï´Ù. ÀÌ »õ·Î¿î ½Ã¼³Àº ¹ÙÀÌ·¯½º Ŭ¸®¾î·±½º¿Í ¹ÙÀÌ¿À ¼¼ÀÌÇÁƼÀÇ µ¿½Ã Å×½ºÆ®¸¦ Áö¿øÇϵµ·Ï Ưº°È÷ ¼³°èµÇ¾ú½À´Ï´Ù.

»ý¹° Á¦Á¦¿¡¼­ À¯ÇØÇÑ ¹ÙÀÌ·¯½º¸¦ °Ë»çÇÏ´Â µ¥´Â ¿©·¯ °¡Áö ¹æ¹ýÀÌ »ç¿ëµË´Ï´Ù. ¾Ë·ÁÁø ¹× ¾Ë·ÁÁöÁö ¾ÊÀº ¿À¿° ¹ÙÀÌ·¯½º¸¦ Á¤È®ÇÏ°í ½Å¼ÓÇÏ°Ô °ËÃâÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â Â÷¼¼´ë ½ÃÄö¼­ÀÇ ÃâÇöÀ¸·Î ±× ¼ö°¡ Á¡Á¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. Â÷¼¼´ë ½ÃÄö¼­´Â ±¤¹üÀ§ÇÑ ¹ÙÀÌ·¯½º ¿À¿°¹°ÁúÀÇ ¹Î°¨ÇÏ°í Æ¯ÀÌÇÑ °Ë»ç¸¦ °¡´ÉÇÏ°Ô ÇÏ¿© ½ÃÀå ¼ºÀå ÀáÀç·ÂÀ» âÃâÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2023³â 7¿ù, Integrated DNA Technologies´Â 'xGen Respiratory Virus Amplicon Panel'À̶ó´Â »õ·Î¿î Â÷¼¼´ë ½ÃÄö½Ì ¼Ö·ç¼ÇÀ» ¹ßÇ¥Çß½À´Ï´Ù.

¶ÇÇÑ, Àΰ£ ¸é¿ª°áÇÌ ¹ÙÀÌ·¯½º, °£¿°, µðÄ«¹ÙÀÌ·¯½º µî ¿©·¯ À¯ÇüÀÇ ¹ÙÀÌ·¯½º¼º Áúȯ¿¡ ÀÇÇØ ¹ÙÀÌ·¯½ºÀÇ ¾ÈÀü¼º°ú ÇコÄÉ¾î »ê¾÷¿¡¼­ÀÇ ±× Á߿伺¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ À¯ÀüÀÚ Ä¡·á¿Í ¸ÂÃãÇü ÀÇ·áÀÇ Çʿ伺¿¡ ÀÇÇØ Ç¥ÀûÀ» Á¼Èù Ç×¹ÙÀÌ·¯½º Ä¡·á³ª ¸é¿ª ¹ÝÀÀÀÇ °­È­°¡ °¡´ÉÇØÁ® ³ª¾Æ°¡ ½ÃÀå¿¡ Å« ¼ºÀåÀÇ °¡´É¼ºÀ» âÃâÇϰí ÀÖ½À´Ï´Ù.

¹ÙÀÌ·¯½º Ŭ¸®¾î·±½º ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

¹ÙÀÌ·¯½º Ŭ¸®¾î·±½º ¹ý ºÐ¾ß´Â À¯ÀÍÇÑ Æ¯¼º°ú ¼¼°èÀÇ ½ÅÇü ¹ÙÀÌ·¯½º À§ÇùÀÇ »ó½ÂÀ¸·Î ÁÖ¸ñÇÒ¸¸ ÇÑ Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.

¹é½Å ºÎ¼­°¡ ÃÖ´ë Á¡À¯À²À» Â÷ÁöÇßÀ¸³ª, ÀÌ´Â ¹é½Å¿¡ ´ëÇÑ ¼ö¿ä¿Í ¿ä±¸»çÇ×ÀÌ Áõ°¡ÇÏ¿© ȯÀÚÀÇ ¿¹¹æÁ¢Á¾À» ÃËÁøÇϱâ À§ÇÑ ´Ù¾çÇÑ À¯ÇüÀÇ ¹é½Å¿¡ ÀÖ½À´Ï´Ù.

CRO ºÐ¾ß´Â Ãʱ⠴ܰèÀÇ °³¹ß°ú ½ÃÇè ¼­ºñ½º ¾Æ¿ô¼Ò½ÌÀÇ º¸±ÞÀ¸·Î ÀÎÇØ »ó´çÇÑ ¼ºÀå·üÀ» º¸ÀÔ´Ï´Ù.

°Å´ëÇÑ ¹Ì°³Ã´ ½ÃÀåÀÇ Á¸Àç¿Í °¡Ã³ºÐ ¼Òµæ Áõ°¡·Î ¾Æ½Ã¾ÆÅÂÆò¾çÀÌ °¡Àå ºü¸£°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù.

ºÏ¹Ì´Â ¹ÙÀÌ·¯½º Ŭ¸®¾î·±½ºÀÇ Á߿伺¿¡ ´ëÇÑ ÀνÄÀÌ ³ô±â ¶§¹®¿¡ ¼¼°è ½ÃÀåÀ» ¼®±ÇÇϰí ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå ±â¾÷Àº Charles River Laboratories, Merck KgaA, Syngene International Limited, WuXi Biologics, Clean Cells, Allure Medical Group µîÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå Á¶»ç ¹æ¹ý

Á¦4Àå ¼¼°èÀÇ ¹ÙÀÌ·¯½º Ŭ¸®¾î·±½º ½ÃÀå ÀλçÀÌÆ®

Á¦5Àå ¼¼°èÀÇ ¹ÙÀÌ·¯½º Ŭ¸®¾î·±½º ½ÃÀå : ¹æ¹ýº°

Á¦6Àå ¼¼°èÀÇ ¹ÙÀÌ·¯½º Ŭ¸®¾î·±½º ½ÃÀå : ¿ëµµº°

Á¦7Àå ¼¼°è ¹ÙÀÌ·¯½º Ŭ¸®¾î·±½º ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

Á¦8Àå ¼¼°èÀÇ ¹ÙÀÌ·¯½º Ŭ¸®¾î·±½º ½ÃÀå : Áö¿ªº°

Á¦9Àå °æÀï ±¸µµ

Á¦10Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

AJY
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global viral clearance market size is expected to reach USD 1464.76 million by 2032, according to a new study by Polaris Market Research. The report "Viral Clearance Market Share, Size, Trends, Industry Analysis Report, By Method (Viral Removal Method, Viral Inactivation Method, and Viral Detection Method); By Application; By End User; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The growing demand for biosimilars and generics worldwide and greater need for sophisticated and cheap therapies for chronic diseases, are prominent factors driving the market's growth. Additionally, the surging penetration for the detection of virus removal or inactivation during the early stages of development and rising preference for outsourcing of viral clearances among leading pharma and biotechnology companies, are further anticipated to boost global market growth.

For instance, in June 2023, Texcell, announced about the opening of its newest testing facility in North America that shows company's commitment towards advancing the viral safety of biotherapeutics and medical devices. The new facility is specially designed to support simultaneous viral clearance and biosafety studies.

There are several methods being used for testing of harmful viruses in biologics. There is an increasing proliferation for the advent of next-generation sequencing which holds great promise in accurate and fast detection of known and unknown contaminating viruses. It allows sensitive and specific testing of wide range of viral contaminants, creating a growth potential for the market. For instance, in July 2023, Integrated DNA Technologies, unveiled its new next-generation sequencing solution called "xGen Respiratory Virus Amplicon Panel".

Furthermore, there has been an increase in the awareness about viral safety and its significance in the healthcare industry, which has been underlined by several types of viral illnesses like Human Immunodeficiency Virus, hepatitis, and Zika virus. Also, the need for gene treatments and personalized medicine that allows for the development of targeted antiviral treatments and enhanced immune response, which in turn, generating huge growth potential for the market.

Viral Clearance Market Report Highlights

Viral removal method segment accounted for the noteworthy share, due to its beneficial properties and rising emergence of new virus threats globally

Vaccines segment held the largest share, that is driven by increasing demand and need for various types of vaccines to boost immunization of patient

CROs segment will grow at substantial growth rate, on account of growing prevalence for outsourcing of early-phase development and testing services

Asia Pacific will grow fastest, due to presence of huge untapped market and rising disposable income

North America dominated the global market, on account of region's greater awareness about the importance of viral clearance

The key market players include Charles River Laboratories, Merck KgaA, Syngene International Limited, WuXi Biologics, Clean Cells, and Allure Medical Group

Polaris Market Research has segmented the viral clearance market report based on method, application, end user, and region:

Viral Clearance, Method Outlook (Revenue - USD Million, 2019 - 2032)

Viral Clearance, Application Outlook (Revenue - USD Million, 2019 - 2032)

Viral Clearance, End User Outlook (Revenue - USD Million, 2019 - 2032)

Viral Clearance, Regional Outlook (Revenue - USD Million, 2019 - 2032)

Table of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Global Viral Clearance Market Insights

5. Global Viral Clearance Market, by Method

6. Global Viral Clearance Market, by Application

7. Global Viral Clearance Market, by End User

8. Global Viral Clearance Market, by Geography

9. Competitive Landscape

10. Company Profiles

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â